[Clinical experience with sultamicillin fine granules in pediatric field]. 1988

T Haruta, and S Kuroki, and H Yamamoto, and K Okura, and T Tsutsui, and Y Kobayashi
Department of Pediatrics, Kobe Central Municipal Hospital.

Sultamicillin fine granules were used orally in 18 pediatric patients with infections in doses ranging 7.3-10.0 mg/kg t.i.d. or q.i.d. The following is a summary of the results: 1. Clinical efficacies in 16 cases with tonsillitis were excellent in 13 cases, good in 2 cases and fair in 1 case. Efficacy in 1 case of bronchitis and 1 case of pneumonia were good. The overall efficacy rate in the 18 cases was 94.4%. 2. Four out of 5 strains of Staphylococcus aureus were eradicated but 1 strain persisted. Three out of 7 strains of Haemophilus influenzae were rated as eradicated, 1 strain as decreased and 3 strains as persisted. Two strains of Streptococcus pyogenes and 3 strains of Haemophilus parainfluenzae were eradicated. The bacteriological efficacy rate for the 17 strains was 70.6%. Four strains out of the 17 were found to produce beta-lactamase and 3 strains were suspected, to produce the enzyme, but of these 7 strains, 5 strains were eradicated. 3. Diarrhea and loose stool were observed as side effects in each of 2 cases. It appeared that diarrhea was related to this drug. A slight elevation of GOT was observed in 1 case in laboratory tests. 4. This drug appears to be easy for children to take in terms of taste and smell.

UI MeSH Term Description Entries
D008297 Male Males
D012141 Respiratory Tract Infections Invasion of the host RESPIRATORY SYSTEM by microorganisms, usually leading to pathological processes or diseases. Respiratory System Infections,Upper Respiratory Tract Infection,Upper Respiratory Tract Infections,Infections, Respiratory,Infections, Respiratory Tract,Infections, Upper Respiratory,Infections, Upper Respiratory Tract,Respiratory Infections,Upper Respiratory Infections,Infection, Respiratory System,Infection, Respiratory Tract,Respiratory Infection, Upper,Respiratory System Infection,Respiratory Tract Infection
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D002675 Child, Preschool A child between the ages of 2 and 5. Children, Preschool,Preschool Child,Preschool Children
D004304 Dosage Forms Completed forms of the pharmaceutical preparation in which prescribed doses of medication are included. They are designed to resist action by gastric fluids, prevent vomiting and nausea, reduce or alleviate the undesirable taste and smells associated with oral administration, achieve a high concentration of drug at target site, or produce a delayed or long-acting drug effect. Dosage Form,Form, Dosage,Forms, Dosage
D004341 Drug Evaluation Any process by which toxicity, metabolism, absorption, elimination, preferred route of administration, safe dosage range, etc., for a drug or group of drugs is determined through clinical assessment in humans or veterinary animals. Evaluation Studies, Drug,Drug Evaluation Studies,Drug Evaluation Study,Drug Evaluations,Evaluation Study, Drug,Evaluation, Drug,Evaluations, Drug,Studies, Drug Evaluation,Study, Drug Evaluation
D004359 Drug Therapy, Combination Therapy with two or more separate preparations given for a combined effect. Combination Chemotherapy,Polychemotherapy,Chemotherapy, Combination,Combination Drug Therapy,Drug Polytherapy,Therapy, Combination Drug,Chemotherapies, Combination,Combination Chemotherapies,Combination Drug Therapies,Drug Polytherapies,Drug Therapies, Combination,Polychemotherapies,Polytherapies, Drug,Polytherapy, Drug,Therapies, Combination Drug
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000367 Age Factors Age as a constituent element or influence contributing to the production of a result. It may be applicable to the cause or the effect of a circumstance. It is used with human or animal concepts but should be differentiated from AGING, a physiological process, and TIME FACTORS which refers only to the passage of time. Age Reporting,Age Factor,Factor, Age,Factors, Age

Related Publications

T Haruta, and S Kuroki, and H Yamamoto, and K Okura, and T Tsutsui, and Y Kobayashi
December 1988, The Japanese journal of antibiotics,
T Haruta, and S Kuroki, and H Yamamoto, and K Okura, and T Tsutsui, and Y Kobayashi
December 1988, The Japanese journal of antibiotics,
T Haruta, and S Kuroki, and H Yamamoto, and K Okura, and T Tsutsui, and Y Kobayashi
December 1988, The Japanese journal of antibiotics,
T Haruta, and S Kuroki, and H Yamamoto, and K Okura, and T Tsutsui, and Y Kobayashi
December 1988, The Japanese journal of antibiotics,
T Haruta, and S Kuroki, and H Yamamoto, and K Okura, and T Tsutsui, and Y Kobayashi
December 1988, The Japanese journal of antibiotics,
T Haruta, and S Kuroki, and H Yamamoto, and K Okura, and T Tsutsui, and Y Kobayashi
September 1994, The Japanese journal of antibiotics,
T Haruta, and S Kuroki, and H Yamamoto, and K Okura, and T Tsutsui, and Y Kobayashi
December 1988, The Japanese journal of antibiotics,
T Haruta, and S Kuroki, and H Yamamoto, and K Okura, and T Tsutsui, and Y Kobayashi
December 1988, The Japanese journal of antibiotics,
T Haruta, and S Kuroki, and H Yamamoto, and K Okura, and T Tsutsui, and Y Kobayashi
December 1988, The Japanese journal of antibiotics,
T Haruta, and S Kuroki, and H Yamamoto, and K Okura, and T Tsutsui, and Y Kobayashi
December 1988, The Japanese journal of antibiotics,
Copied contents to your clipboard!